Bendazac L-lysine

Catalog No. A17975

Bendazac L-Lysine is one of agents that have been introduced for the management of cataracts, protecting the level of vision in patients, thus delaying the need for surgical intervention.
Catalog Num A17975
M. Wt 428.49
Formula C22H28N4O5
Purity >98%
Storage at -20°C 3 years Powder
CAS No. 81919-14-4
Synonyms Bendazac lysine; AF 1934; AF-1934; AF1934
SMILES N[C@@H](CCCCN)C(O)=O.O=C(O)COC1=NN(CC2=CC=CC=C2)C3=C1C=CC=C3
Bendazac L-Lysine is one of agents that have been introduced for the management of cataracts, protecting the level of vision in patients, thus delaying the need for surgical intervention.
In vitro DMSO 3 mg/mL (7 mM)
Water 83 mg/mL (193.7 mM)
Ethanol Insoluble
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
0.1 mM 23.34 mL 116.69 mL 233.38 mL
0.5 mM 4.67 mL 23.34 mL 46.68 mL
1 mM 2.33 mL 11.67 mL 23.34 mL
5 mM 0.47 mL 2.33 mL 4.67 mL

*The above data is based on the productmolecular weight 428.49. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.